The contract is for delivery of contrast agents, including the following packages: Package # 1 1) Gadopentetate dimeglumine 2) Gadobutrol 3) Iopromide
According to the procurement of contrast media from sample hospitals in 16 cities, the CT contrast media with market shares ranking top 4 in China are iohexol, iopromide
, ioversol and iodixanol successively, with market shares of 20.
Patients received a weight-adapted dose of intravenous non-ionic contrast media, iopromide
300 mg/mL (Ultravist 300, Bayer).
Delivery to the arteries was improved when paclitaxel was combined with hydrophilic contrast medium, iopromide
, suggesting that a drug carrier is needed to increase drug retention within the artery .
During coronary angiography, iopromide
(Ultravist 370, Schering AG, Berlin, Germany) was used as the contrast agent in all patients and control participants.
3) Richardson's team screened drinking water for five common ICM (iopamidol, iopromide
, diatrizo-ate, iomeprol, and iohexol).
An opaque medium containing Iopromide
was used to view coronary arteries (Ultravist-370 mgl/l, Germany).
Sialography was performed using Iopromide
(ultravist-300) as a contrast media for both right and left parotid gland after the clinical symptoms subsided.
One study of note enrolled 208 patients in a comparison of the renal safety, occurrence of cardiovascular adverse events, and diagnostic image quality of the company's isosmolar contrast media iodixanol (Visipaque) compared with the low-osmolar contrast media iopromide
2]-Globulin lopamiro Iopamidol 242 (cathodal site) Omnitrast Iohexol 242 Omnipaque Iohexol 242 Ultravist Iopromide
242 R-Globulin (anodal site) Hexabrix Sodium-meglumine 243 ioxaglate R-Globulin (middle site) Optiray Ioversol 244 Iomeron Iomeprol 244
A first-ever 208-person study comparing the renal safety, occurrence of cardiovascular adverse events and diagnostic image quality of GE Healthcare's isosmolar contrast media (CM) iodixanol (Visipaque) and the low-osmolar CM iopromide
in select patients concluded iodixanol is associated with lower incidence of contrast-induced neuropathy (CIN) and cardiovascular events (CV) than iopromide
, when used in patients with chronic kidney disease.
22: contrast media for CT - IOPROMIDE
,Package - 23: pegylated interferon alpha 2 with a compatible thereto, rybaviryna dosed regardless of body weight, for the treatment of hepatitis C.